Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Cell And Gene Therapy Clinical Trial Services Market Report 2024

Cell And Gene Therapy Clinical Trial Services Global Market Report 2024 – By Service (Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services), By Therapy Type (Gene Therapy, Cell Therapy, Gene Modified Cell Therapy), By Indication (Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications), By End-Use (Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Cell And Gene Therapy Clinical Trial Services Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : June 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cell And Gene Therapy Clinical Trial Services Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cell And Gene Therapy Clinical Trial Services Market Definition And Segments

Cell and gene therapy clinical trial services refer to specialized services offered by contract research organizations (CROs) or clinical trial management corporations to facilitate the design, implementation, and management of clinical trials for cell and gene therapies. These services, which range from protocol design and patient recruiting to regulatory compliance and data administration, serve as the foundation for trials to progress smoothly, ensuring precision, efficacy, and adherence to high standards.

The main types of cell and gene therapy clinical trial services include clinical trial design and planning, supply and logistic services, regulatory affairs and compliance, data management and biostatics, site management and monitoring, and others. Clinical trial design and planning involve creating and organizing the blueprint for clinical trials, deciding what the trial will test, and how it will be conducted. Several types of therapies are included, such as gene therapy, cell therapy, and gene-modified cell therapy, which are used for various indications, such as oncology, hematology, metabolic disorders, infectious diseases, neurology, cardiovascular diseases, musculoskeletal disorders, and others. These are used by various end-users, including pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes, and others.

The cell and gene therapy clinical trial services market covered in this report is segmented –

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

The cell and gene therapy clinical trial services market size has grown rapidly in recent years. It will grow from $3.44 billion in 2023 to $3.79 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for effective treatments for rare genetic disorders, increased government funding for research in regenerative medicine, increased understanding of molecular mechanisms underlying various diseases, and increased awareness of the potential of personalized medicine.

The cell and gene therapy clinical trial services market size is expected to see rapid growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing global incidence of genetic and auto-immune diseases, rising public and private sector funding for gene therapy research, growing adoption of novel technologies, and a rise in the number of genetic defects. Major trends in the forecast period include the adoption of AI, the adoption of machine learning, the adoption of personalized medicine, technological advancements, and gene therapies.

Role Of Cell And Gene Therapy Trials In Tackling Genetic Diseases

The rising incidence of genetic disease is expected to propel the growth of the cell and gene therapy clinical trial services market going forward. Genetic diseases are ailments caused by variations in a person's DNA or genetic composition. The incidence of genetic diseases is on the rise due to numerous factors, including the increased availability of genetic testing, the occurrence of genetic mutations, and the prevalence of consanguineous marriage. Cell and gene therapy clinical trial services address the rising incidence of genetic diseases by encouraging the development of novel treatments, tailoring therapies to individual patients, accelerating the translation of research into clinical practice, and expanding the options available to patients suffering from genetic disorders. For instance, in July 2022, according to the Cystic Fibrosis (CF) Foundation, a US-based non-profit organization, there had been an upsurge in the number of people with cystic fibrosis. In 2022, cystic fibrosis affected almost 40,000 children and adults in the United States, and over 105,000 people worldwide have been diagnosed. Therefore, the rising incidence of genetic disease is driving the growth of the cell and gene therapy clinical trial services market.

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

Innovative Solutions In Cell And Gene Therapy Clinical Trial Services Market

Major companies operating in the cell and gene therapy clinical trial services market are focusing their efforts on introducing advanced technology with customer relationship management system technology, to improve efficiency, and gain a competitive edge in the market. The customer relationship management system utilized by cell and gene therapy clinical trial services streamlines and coordinates interactions with trial participants, healthcare providers, and other stakeholders throughout the clinical trial process. For instance, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company, launched the Cell and Gene Therapy (CGT) Integration Hub, a platform that aims to increase connectivity and streamline processes throughout the cell and gene therapy treatment pathway. This platform is backed by AmerisourceBergen's customer relationship management (CRM) system and attempts to streamline the path-to-care process, in part by giving physicians and patient services teams better visibility across the therapy development and delivery process. The CGT Integration Hub, which includes features such as expedited benefits investigation, real-time status tracking, and proactive alerts, aims to simplify care coordination, minimize barriers, and improve the entire patient and provider experience when delivering cell and gene therapies.

Kyowa Kirin Co. Ltd. Expands Genetic Medicine Portfolio With Orchard Therapeutics Acquisition

In January 2024, Kyowa Kirin Co. Ltd., a Japan-based pharmaceutical company, acquired Orchard Therapeutics Limited for an undisclosed amount. Through this acquisition, Kyowa Kirin aims to enhance its focus on addressing the unmet medical needs of individuals with genetic and severe diseases by leveraging Orchard's expertise in developing and commercializing gene therapies for rare diseases. Orchard Therapeutics Limited is a UK-based biotechnology company primarily dedicated to the research, development, and commercialization of gene therapies for rare diseases.

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell and gene therapy clinical trial services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell and gene therapy clinical trial services market includes revenues earned by providing services, such as regulatory pathways navigation, logistics management, patient retention strategy management, and biomarker analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cell and gene therapy clinical trial services market research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy clinical trial services market statistics, including cell and gene therapy clinical trial services industry global market size, regional shares, competitors with a cell and gene therapy clinical trial services market share, detailed cell and gene therapy clinical trial services market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy clinical trial services industry. This cell and gene therapy clinical trial services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cell And Gene Therapy Clinical Trial Services Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $3.79 billion
Revenue Forecast In 2033 $5.64 billion
Growth Rate CAGR of 10.4% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services
2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy
3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cell And Gene Therapy Clinical Trial Services Market Characteristics

    3. Cell And Gene Therapy Clinical Trial Services Market Trends And Strategies

    4. Cell And Gene Therapy Clinical Trial Services Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Cell And Gene Therapy Clinical Trial Services Market Size and Growth

    5.1. Global Cell And Gene Therapy Clinical Trial Services Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cell And Gene Therapy Clinical Trial Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cell And Gene Therapy Clinical Trial Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cell And Gene Therapy Clinical Trial Services Market Segmentation

    6.1. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Clinical Trial Design And Planning

    Supply And Logistic Services

    Regulatory Affairs And Compliance

    Data Management And Biostatics

    Site Management And Monitoring

    Other Services

    6.2. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Gene Therapy

    Cell Therapy

    Gene Modified Cell Therapy

    6.3. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oncology

    Hematology

    Metabolic Disorders

    Infectious Diseases

    Neurology

    Cardiovascular Diseases

    Musculoskeletal Disorders

    Other Indications

    6.4. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Pharmaceutical And Biotechnology Companies

    Contract Research Organizations

    Academic And Research Institutes

    Other End-Users

    7. Cell And Gene Therapy Clinical Trial Services Market Regional And Country Analysis

    7.1. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market

    8.1. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cell And Gene Therapy Clinical Trial Services Market

    9.1. China Cell And Gene Therapy Clinical Trial Services Market Overview

    9.2. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cell And Gene Therapy Clinical Trial Services Market

    10.1. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cell And Gene Therapy Clinical Trial Services Market

    11.1. Japan Cell And Gene Therapy Clinical Trial Services Market Overview

    11.2. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cell And Gene Therapy Clinical Trial Services Market

    12.1. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cell And Gene Therapy Clinical Trial Services Market

    13.1. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cell And Gene Therapy Clinical Trial Services Market

    14.1. South Korea Cell And Gene Therapy Clinical Trial Services Market Overview

    14.2. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cell And Gene Therapy Clinical Trial Services Market

    15.1. Western Europe Cell And Gene Therapy Clinical Trial Services Market Overview

    15.2. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cell And Gene Therapy Clinical Trial Services Market

    16.1. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cell And Gene Therapy Clinical Trial Services Market

    17.1. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cell And Gene Therapy Clinical Trial Services Market

    18.1. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cell And Gene Therapy Clinical Trial Services Market

    19.1. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cell And Gene Therapy Clinical Trial Services Market

    20.1. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market

    21.1. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market Overview

    21.2. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cell And Gene Therapy Clinical Trial Services Market

    22.1. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cell And Gene Therapy Clinical Trial Services Market

    23.1. North America Cell And Gene Therapy Clinical Trial Services Market Overview

    23.2. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cell And Gene Therapy Clinical Trial Services Market

    24.1. USA Cell And Gene Therapy Clinical Trial Services Market Overview

    24.2. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cell And Gene Therapy Clinical Trial Services Market

    25.1. Canada Cell And Gene Therapy Clinical Trial Services Market Overview

    25.2. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cell And Gene Therapy Clinical Trial Services Market

    26.1. South America Cell And Gene Therapy Clinical Trial Services Market Overview

    26.2. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cell And Gene Therapy Clinical Trial Services Market

    27.1. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cell And Gene Therapy Clinical Trial Services Market

    28.1. Middle East Cell And Gene Therapy Clinical Trial Services Market Overview

    28.2. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cell And Gene Therapy Clinical Trial Services Market

    29.1. Africa Cell And Gene Therapy Clinical Trial Services Market Overview

    29.2. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape And Company Profiles

    30.1. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape

    30.2. Cell And Gene Therapy Clinical Trial Services Market Company Profiles

    30.2.1. Thermo Fisher Scientific Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Sharp Services LLC

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. IQVIA

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Laboratory Corporation of America Holdings

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. ICON plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Cell And Gene Therapy Clinical Trial Services Market Other Major And Innovative Companies

    31.1. Syneos Health Inc.

    31.2. Catalent Pharma Solutions Inc.

    31.3. Charles River Laboratories International Inc.

    31.4. Parexel International Corporation

    31.5. PRA Health Sciences Inc.

    31.6. Covance Inc.

    31.7. Medpace Holdings Inc.

    31.8. BioClinica Inc.

    31.9. Precision Medicine Group LLC

    31.10. Worldwide Clinical Trials LLC

    31.11. Clinigen Group plc

    31.12. Evidera Inc.

    31.13. Advarra LLC

    31.14. Veristat LLC

    31.15. Clinipace Inc.

    32. Global Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking

    33. Global Cell And Gene Therapy Clinical Trial Services Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Cell And Gene Therapy Clinical Trial Services Market

    35. Cell And Gene Therapy Clinical Trial Services Market Future Outlook and Potential Analysis

    35.1 Cell And Gene Therapy Clinical Trial Services Market In 2028 - Countries Offering Most New Opportunities

    35.2 Cell And Gene Therapy Clinical Trial Services Market In 2028 - Segments Offering Most New Opportunities

    35.3 Cell And Gene Therapy Clinical Trial Services Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cell And Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Cell And Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Thermo Fisher Scientific Inc. Financial Performance
  • Table 76: Sharp Services LLC Financial Performance
  • Table 77: IQVIA Financial Performance
  • Table 78: Laboratory Corporation of America Holdings Financial Performance
  • Table 79: ICON plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cell And Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Cell And Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 76: Sharp Services LLC Financial Performance
  • Figure 77: IQVIA Financial Performance
  • Figure 78: Laboratory Corporation of America Holdings Financial Performance
  • Figure 79: ICON plc Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Cell Isolation Global Market Report 2024 – By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source (Bone Marrow, Adipose Tissues, Cord Blood Or Embryonic Stem Cells, Other Cell Sources), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration Or Regenerative Medicines, In-vitro Diagnostics, Other Applications), By End-User (Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Hospitals And Diagnostic Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Harvesting Global Market Report 2024 – By Type (Manual Cell Harvesters, Automated Cell Harvesters), By Distribution Channel (Retail, Direct Tenders), By End-Users (Biotechnology and Biopharmaceutical Companies, Research Institute, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Therapy Technologies Global Market Report 2024 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control), By End User (Life Science Companies, Research Institutes And Cell Banks) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Therapy Global Market Report 2024 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Surface Marker Detection Global Market Report 2024 – By Product (Flow Cytometry, Hematology Analyzers, Reagents and Kits), By Application (Disease Diagnosis, Diseases Identification, Research for Drug Discovery, Cytological Academic Research), By End-Users (Pharmaceutical and Biotechnology Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Separation Global Market Report 2024 – By Cell Type (Human Cells, Animal Cells), By Type (Gradient centrifugation, Surface markers separation, Fluorescence activated cell sorting, Magnetic cell sorting), By Product (Consumables, Instruments), By Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, Therapeutics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Regeneration Medicine Global Market Report 2024 – By Product (Therapeutics, Tools, Banks, Services), By Therapeutic Category (Dermatology, Musculoskeletal, Immunology And Inflammation, Oncology, Cardiovascular, Ophthalmology, Other Therapeutic Categories), By End-User (Hospitals And Clinics, Commercial Industries, Government And Academic Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Lysis And Fractionation Global Market Report 2024 – By Type (Mammalian Cells, Microbial Cells), By Application (Nucleic Acid Purification And Isolation, Protein Purification And Isolation), By End-User (Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the cell and gene therapy clinical trial services market?

Cell and gene therapy clinical trial services refer to specialized services offered by contract research organizations (CROs) or clinical trial management corporations to facilitate the design, implementation, and management of clinical trials for cell and gene therapies. These services, which range from protocol design and patient recruiting to regulatory compliance and data administration, serve as the foundation for trials to progress smoothly, ensuring precision, efficacy, and adherence to high standards. For further insights on the cell and gene therapy clinical trial services market, request a sample here

How will the cell and gene therapy clinical trial services market drivers and restraints affect the cell and gene therapy clinical trial services market dynamics? What forces will shape the cell and gene therapy clinical trial services industry going forw

The cell and gene therapy clinical trial services market major growth driver - Role Of Cell And Gene Therapy Trials In Tackling Genetic Diseases. For further insights on the cell and gene therapy clinical trial services market, request a sample here

What is the forecast market size or the forecast market value of the cell and gene therapy clinical trial services market?

The cell and gene therapy clinical trial services market size has grown rapidly in recent years. It will grow from $3.44 billion in 2023 to $3.79 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for effective treatments for rare genetic disorders, increased government funding for research in regenerative medicine, increased understanding of molecular mechanisms underlying various diseases, and increased awareness of the potential of personalized medicine. The cell and gene therapy clinical trial services market size is expected to see rapid growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing global incidence of genetic and auto-immune diseases, rising public and private sector funding for gene therapy research, growing adoption of novel technologies, and a rise in the number of genetic defects. Major trends in the forecast period include the adoption of AI, the adoption of machine learning, the adoption of personalized medicine, technological advancements, and gene therapies. For further insights on the cell and gene therapy clinical trial services market, request a sample here

How is the cell and gene therapy clinical trial services market segmented?

The cell and gene therapy clinical trial services market is segmented
1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services
2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy
3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-UsersFor further insights on the cell and gene therapy clinical trial services market, request a sample here

Which region has the largest share of the cell and gene therapy clinical trial services market? What are the other regions covered in the report?

North America was the largest region in the cell and gene therapy clinical trial services market in 2023. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the cell and gene therapy clinical trial services market, request a sample here.

Who are the major players in the cell and gene therapy clinical trial services market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc. For further insights on the cell and gene therapy clinical trial services market, request a sample here.

What are the key trends in the cell and gene therapy clinical trial services market?

Major trend in the cell and gene therapy clinical trial services market - Innovative Solutions In Cell And Gene Therapy Clinical Trial Services Market. For further insights on the cell and gene therapy clinical trial services market, request a sample here.

What are the major opportunities in the cell and gene therapy clinical trial services market? What are the strategies for the cell and gene therapy clinical trial services market?

For detailed insights on the major opportunities and strategies in the cell and gene therapy clinical trial services market, request a sample here.

How does the cell and gene therapy clinical trial services market relate to the overall economy and other similar markets?

For detailed insights on cell and gene therapy clinical trial services market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cell and gene therapy clinical trial services industry?

For detailed insights on the mergers and acquisitions in the cell and gene therapy clinical trial services industry, request a sample here.

What are the key dynamics influencing the cell and gene therapy clinical trial services market growth? SWOT analysis of the cell and gene therapy clinical trial services market.

For detailed insights on the key dynamics influencing the cell and gene therapy clinical trial services market growth and SWOT analysis of the cell and gene therapy clinical trial services industry, request a sample here.